Tnkase 50 MG kits
Ended Awarded
- Contract number
- SPE2D325F323S
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,110
Award facts
- Contract value 100% obligated
- $16,109.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Genentech USA, Inc. for TNKase 50 mg kits with a ceiling value of $16,109.55. This firm fixed-price delivery order, executed on August 15, 2025, is scheduled for completion by August 20, 2025, and will be performed at Genentech's facility in South San Francisco, California. TNKase (tenecteplase) is a thrombolytic agent used in acute myocardial infarction treatment, representing a critical pharmaceutical product within the federal medical supply chain. The contract was awarded without a set-aside designation, indicating open competition among qualified vendors.
Genentech USA, Inc. maintains an extensive portfolio of federal contracts and indefinite delivery vehicles supporting defense and civilian healthcare agencies, including a $4.9 billion Federal Supply Schedule contract with the Department of Veterans Affairs and a $27.9 million indefinite delivery contract with the Defense Logistics Agency Troop Support Medical. This delivery order represents a targeted procurement under Genentech's existing contract framework to replenish medical supplies required by the federal government's health emergency preparedness and ongoing medical support operations. The company, a foreign-owned biotechnology and pharmaceutical manufacturer registered in SAM.gov since 2008, has consistently provided specialized medications and biologics to support national medical supply chains and strategic stockpiles across multiple federal agencies.
Quick answers
Who was awarded contract SPE2D325F323S?
SPE2D325F323S was awarded to Genentech Usa, Inc. by Medical Supply Chain (Troop Support) on August 15, 2025.
How much is contract SPE2D325F323S worth?
The government has obligated $16,110 on SPE2D325F323S.
Is contract SPE2D325F323S an order under another contract?
Yes. SPE2D325F323S is a delivery order under SPE2D021D0005, an indefinite delivery contract.
Was contract SPE2D325F323S competed?
The extent of competition for SPE2D325F323S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award